Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04245839
Title A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) (TRANSCEND FL)
Acronym TRANSCEND FL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | AUT

Facility Status City State Zip Country Details
Local Institution - 111 Santa Monica California 90095 United States Details
Local Institution - 107 Aurora Colorado 80045 United States Details
Local Institution - 105 New Haven Connecticut 06520 United States Details
Local Institution - 103 Chicago Illinois 60611 United States Details
Local Institution - 109 Niles Illinois 60714 United States Details
Local Institution - 102 Baltimore Maryland 21201 United States Details
Local Institution - 100 Boston Massachusetts 02114 United States Details
Local Institution - 101 Boston Massachusetts 02215 United States Details
Local Institution - 116 New York New York 10021 United States Details
Local Institution - 110 Charlotte North Carolina 28204 United States Details
Local Institution - 112 Cleveland Ohio 44195 United States Details
Local Institution - 114 Portland Oregon 97213 United States Details
Local Institution - 117 Philadelphia Pennsylvania 19104 United States Details
Local Institution - 113 Sioux Falls South Dakota 57105 United States Details
Local Institution - 104 Houston Texas 77030 United States Details
Local Institution - 115 Charlottesville Virginia 22903 United States Details
Local Institution - 108 Seattle Washington 98109 United States Details
Local Institution - UNK-201 Salzburg 5020 Austria Details
Local Institution - 450 Wien 1090 Austria Details
Local Institution - 150 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 151 Montreal Quebec H1T 2M4 Canada Details
Local Institution - 252 Lille 59037 France Details
Local Institution - 251 Montpellier CEDEX 5 34295 France Details
Local Institution - 250 Pierre-Benite CEDEX 69495 France Details
Local Institution - 501 Köln 50937 Germany Details
Local Institution - 502 Munich 81377 Germany Details
Local Institution - 500 Ulm 89081 Germany Details
Local Institution - 300 Bergamo 24127 Italy Details
Local Institution - 301 Naples 80131 Italy Details
Local Institution - 553 Sapporo-shi Hokkaido 0608648 Japan Details
Local Institution - 550 Chuo-ku Tokyo 104-0045 Japan Details
Local Institution - 551 Minato-ku Tokyo 105-8470 Japan Details
Local Institution - 552 Fukuoka 812-8582 Japan Details
Local Institution - 350 Salamanca 37007 Spain Details
Local Institution - 351 Sevilla 41013 Spain Details
Local Institution - 600 Stockholm 14186 Sweden Details
Local Institution - 200 London NW1 2PG United Kingdom Details
Local Institution - 201 Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field